Evidence map›Paper›PMID 39493848›Full record

ArticleFrontiers in microbiology2024

Distribution diversity and expression regulation of class 1 integron promoters in clinical isolates of

Ye Yang, Hui Zhang, Rongqing Zhao, Xuedan Qiu, Jinglu Ye, Wenjun Lu, Qingcao Li, Guangliang Wu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Draft genome sequence of emerging pathogenMicrobiology resource announcements · 2025
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ye YangDepartment of Clinical Laboratory, The Affiliated LiHuiLi Hospital of Ningbo University, Ningbo, China.
Hui ZhangDepartment of Clinical Laboratory, Ninghai County Chengguan Hospital, Ningbo, China.
Rongqing ZhaoDepartment of Clinical Laboratory, The Affiliated LiHuiLi Hospital of Ningbo University, Ningbo, China.
Xuedan QiuDepartment of Clinical Laboratory, The Affiliated LiHuiLi Hospital of Ningbo University, Ningbo, China.
Jinglu YeDepartment of Clinical Laboratory, The Affiliated LiHuiLi Hospital of Ningbo University, Ningbo, China.
Wenjun LuDepartment of Intensive Care Units, The Affiliated LiHuiLi Hospital of Ningbo University, Ningbo, China.
Qingcao LiDepartment of Clinical Laboratory, The Affiliated LiHuiLi Hospital of Ningbo University, Ningbo, China.
Guangliang WuDepartment of Clinical Pharmacy, The Affiliated LiHuiLi Hospital, Ningbo University, Ningbo, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Objective: To investigate the distribution of promoter types in the variable regions of class 1 integrons isolated from clinical isolates of Methods: Ninety seven clinical isolates of Results: Of the clinical isolates, 28.9% ( Conclusion: Class 1 integrons are prevalent in

Indexed as

expression regulationhomologyintegronMorganella morganiipromoter

Identifiers

PMID39493848
PMCPMC11527653

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.